Last reviewed · How we verify
Moviprep
At a glance
| Generic name | Moviprep |
|---|---|
| Also known as | IMP-2, Moviprep, macrogol, Osmotic laxative solution |
| Sponsor | Norgine |
| Modality | Small molecule |
| Therapeutic area | Other |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- MoviPrep® Versus GoLYTELY® Bowel Preparation in Hospitalized Patients Undergoing Colonoscopy (PHASE4)
- 4-L Split-dose Polyethylene Glycol and Bisacodyl and Docusate Sodium Regimen Versus 2-L Split-dose Polyethylene Glycol Plus Oral Simethicone Regimen for Bowel Preparation Before Colonoscopy (NA)
- Efficacy and Safety of mAnnitol in Bowel Preparation During Elective Colonoscopy and Comparison With Moviprep® (PHASE2, PHASE3)
- Beneficial Bacteria Treatment for Autism (PHASE1, PHASE2)
- Assessing the Tolerance and Clinical Benefit of feCAl tranSplantation in patientS With melanOma (PHASE2)
- Effect of Low-volume (1L) vs Intermediate-volume (2L) Bowel Preparation on Cost-effectiveness and Quality of Life (NA)
- A Monocentric Study to Investigate a New Low Dose Oral Gut Cleansing Solution (PHASE2)
- Trial of Faecal Microbiota Transplantation in Cirrhosis (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |